FDA Inspections, Bar-Coding Rank Among Agency’s Regulatory Reform Items
This article was originally published in The Gray Sheet
Executive Summary
FDA is highlighting the inspection process as one area in need of improvement as part of overall HHS regulatory reform efforts
You may also be interested in...
Blood Safety Authority Shift To CDRH Opposed By Blood Centers
Legislation shifting responsibility for the regulation of blood safety screening tests from FDA's Center for Biologics Evaluation and Research to the device center puts an enormous burden on blood organizations, according to America's Blood Centers (ABC)
Blood Safety Authority Shift To CDRH Opposed By Blood Centers
Legislation shifting responsibility for the regulation of blood safety screening tests from FDA's Center for Biologics Evaluation and Research to the device center puts an enormous burden on blood organizations, according to America's Blood Centers (ABC)
Device Bar-Coding Advocated By GPOs; FDA Cost Analysis Awaited
FDA may decide to pursue a medical device bar-code labeling requirement independently of the rulemaking process for drugs and biologics